Compromised anti-tumor responses in tumor necrosis factor-α knockout mice

European Journal of Immunology

Volumn 30, Issue 7, 2000, Pages 1957-1966

  Baxevanis, Constantin N ^a   Voutsas, Ioannis F ^a   Tsitsilonis, Ourania E ^a   Tsiatas, Marinos L ^a   Gritzapis, Angelos D ^a   Papamichail, Michael ^a  

^a SAINT SAVVAS HOSPITAL   (Greece)

Author keywords

Cytotoxicity; TNF knockout; Tumor model

Indexed keywords

FAS LIGAND; PERFORIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; KNOCKOUT MOUSE; LYMPHOKINE ACTIVATED KILLER CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR IMMUNITY; TUMOR MODEL; TUMOR REJECTION;

ANIMALS; CELLS, CULTURED; DENDRITIC CELLS; FIBROSARCOMA; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, KNOCKOUT; NEOPLASMS, EXPERIMENTAL; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033945605     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200007)30:7<1957::AID-IMMU1957>3.0.CO;2-7     Document Type: Article

References (52)

1. Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N. and Williamson, B., An endotoxic-induced serum factor causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 1975. 72: 3660-3665.
2. Palladino, M. A., Shalaby, M. R., Kramer, S. M., Ferraido, B. L., Baughawan, R. A., Deleo, A. B., Crase, D., Marafino, B., Aggarwal, B. B., Figari, I. S., Liggitt, D. and Patton, J. S., Characterization of the antitumor activities of human tumor necrosis factor and the comparison with other cytokines in induction of tumor specific immunity. J. Immunol. 1987. 138: 4023-4027.
3. Palombella, V. J., Mendelsohn, J. and Vilcek, J., Mitogenic action of tumor necrosis factor in human fibroblasts: interaction with epidermal growth factor and platelet-derived growth factor. J. Cell. Physiol. 1988. 135: 23-28.
4. Malik, S. T. A. and Balkwill, F. R., Antiproliferative and antitumor activity of TNF in vitro and in vivo. In Aggarwal, B. B. and Vilcek, J. (Eds.) Tumor necrosis factors: structure, function and mechanism of action. Marcel Decker, New York 1992, pp 239-247.
5. Beutler, B., Tumor necrosis factor. In Beutler, B. (Ed.) Tumor necrosis factors: The molecules and their emerging role in medicine. Raven Press, New York 1992, pp 86-95.
6. Pasparakis, M., Alexopoulou, L, Episkopou, V. and Kollias, G., Immune and inflammatory responses in TNF-α-deficient mice: a critical requirement for TNF-α in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers and in the maturation of the humoral immune response. J. Exp. Med. 1996. 184: 1397-1407.
7. Marino, M. W., Dunn, A., Grail, D., Inghese, M., Noguchi, Y., Richards, E., Jungbluth, A., Wada, H., Moore, M., Williamson, B., Basu, S. and Old, L. J., Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 1997. 94: 8093-8098.
8. Tartaglia, L. A. and Goeddel, D. V., Two TNF receptors. Immunol. Today 1992. 13: 151-153.
9. Tartaglia, L. A., Ayres, T. M., Wong, G. H. W. and Goeddel, D. V., A novel domain within the 55 kDa TNF receptor signals for cell death. Cell 1993. 74: 845-848.
10. Bazzoni, F., Alejos, E. and Beutler, B., Chimeric tumor necrosis factor receptors with constitutive signaling activity. Proc. Natl. Acad. Sci. USA 1995. 92: 5376-5381.
11. Rothe, M., Wong, S. C., Henzel, W. J. and Goeddel, D. V., A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 1993. 78: 681-683.
12. Baxevanis, C. N. and Papamichail, M., Characterization of the anti-tumor immune response in human cancers and strategies for immunotherapy. Crit. Rev. Oncol. Hematol. 1994. 16: 157-179.
13. Baxevanis, C. N., Tsiatas, M. L., Cacullos, N. T., Spanakos, G., Liakos, C., Missitzis, I., Papadhimitriou, S. I. and Papamichail, M., Induction of anti-tumor lymphocytes in cancer patients after brief exposure to supernatants from cultures of anti-CD3-stimulated allogeneic lymphocytes. Br. J. Cancer 1997. 76: 1072-1080.
14. Smith, M. J. and Trogani, J. A., Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol. Today 1995. 16: 202-204.
15. Liu, C. C., Walsh, C. M. and Young, J. D., Perforin: structure and function. Immunol. Today 1995. 16: 194-196.
16. Nagata, S. and Goldstein, P., The Fas death factor. Science 1995. 267: 1449-1452.
17. Lowin, B., Hahne, M., Mattmann C. and Tschopp, J., Cytolytic T cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 1994. 370: 650-652.
18. Lee, R. K., Spielman, J., Zhao, D. Y., Olsen, K. J. and Podack, E. R., Perforin, Fas ligand and tumor necrosis factor are the major cytotoxic molecules used by lymphokine activated killer cells. J. Immunol. 1996. 157: 1914-1919.
19. + cytotoxic T lymphocyte-mediated lysis. J. Immunol. 1993. 150: 4303-4308.
20. Gorelik, L., Bar-Dagan, Y. and Mokyr, M. B., Insight into the mechanism(s) through which TNF promotes the generation of T cell-mediated antitumor cytotoxicity by tumor bearer splenic cells. J. Immunol. 1996. 156: 4298-4305.
21. Vassali, P., The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 1992. 10: 411-426.
22. Asher, A. L., Mule, J. J., Reichert, C. M., Shiloni, E. and Rosenberg, S. A., Studies on the antitumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo. J. Immunol. 1987. 138: 963-968.
23. Gorelik, L., Rubin, M., Prokhorova, A. and Mokyr, M. B., Importance of TNF production for the curative effectiveness of low dose melphalan therapy for mice bearing a large MOPC-315 tumor. J. Immunol. 1995. 154: 3941-3946.
24. Sheehan, K. P. C. and Schreiber, R. D., The synergy and antagonism of IFN-γ and TNF. In Beutler B. (Ed.) Tumor necrosis factors: the molecules and their emerging role in medicine. Raven Press, New York 1992, pp 145-158.
25. Ruddle, N. H., Tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta). Curr. Opin. Immunol. 1992. 4: 327-336.
26. + natural killer cells. J. Immunol. 1991. 147: 2208-2213.
27. Chouaib, S., Bertoglio, G., Blay, J. Y., Marchiol-Fournigault, C. and Fradelizi, D., Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin-2. Proc. Natl. Acad. Sci. USA 1982. 85: 6875-6880.
28. Orange, J. S. and Biron, C. A., Characterization of early IL-12, IFN-αβ, and TNF effects on antiviral state of NK cell responses during murine cytomegalovirus infection. J. Immunol. 1996. 156: 4746-4751.
29. + cytotoxic T lymphocytes. Eur. J. Immunol. 1998. 28: 4162-4169.
30. Sarin, A., Conan, C. M. and Henkart, P. A., Cytotoxic effect of TNF and lymphotoxin on T lymphocytes. J. Immunol. 1995. 155: 3716-3721.
31. Zheng, L., Fisher, G., Miller, R. E., Perschon, J., Lynch D. H. and Lenardo, M. J., Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 1995. 377: 348-350.
32. Auchincloss H. Jr. and Sultan, H., Antigen processing and presentation in transplantation. Curr. Opin. Immunol. 1996. 8: 681-686.
33. Abbas, A. K., Lichtman, A. H. and Pober, J. S., Immune response to tissue transplants. The molecular basis of allorecognition. In Abbas, A., Lichtman, L., Pober, K. (Eds.) Cellular and molecular immunology. Saunders, Philadelphia 1997, pp 364-370.
34. Lowin, B., Hahne, M., Mattmann, C. and Tshopp, J., Cytolytic T cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 1994. 370: 650-652.
35. Kagi, D., Vignaux, F., Ledermann, B., Burki, K., Depreatere, V., Nagata, S., Heugartner, H. and Goldstein, P., Fas and perforin pathways are major mechanisms of T cell-mediated cytotoxicity. Science 1994. 265: 528-530.
36. Wen, T., Kono, K., Shahinian, A., Kiessling, R., Mak, T. W. and Klein, G., CD28 is not required for rejection of unmanipulated syngeneic and autologous tumors. Eur. J. Immunol. 1997. 29: 1988-1996.
37. ck. Eur. J. Immunol. 1995. 25: 3155-3159.
38. Ross, A. J. and Koeffler, H. P., Interactions between TNF and GM-CSF. In Beutler, B. (Ed.). Tumor necrosis factors: the molecules and their emerging role in medicine. Raven Press, New York, 1992, pp 179-189.
39. Inge, E. A., Hess, J. H., Huang, S., Agnet, M., Rothe, J., Bluetmann, H. and Kaufmann, S. H. E., Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon γ and tumor necrosis factor α. J. Exp. Med. 1995. 181: 1615-1623.
40. Scheurich, P., Thoma, B., Ucer, U. and Pfizenmaier, K., Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-α: induction of TNF receptors on human T cells and TNF-α mediated enhancement of T cell responses. J. Immunol. 1988. 138: 1786-1791.
41. Arezana-Seisdedos, F., Mivensen, S. C., Vuillier, F., Fiers, W. and Virelizier, J.-L., Autocrine secretion of tumor necrosis factor under the influence of interferon-γ amplifies HLA-DR gene induction in human monocytes. Proc. Natl. Acad. Sci. USA 1988. 79: 545-550.
42. Vaccarello, L., Wang, Y. L. and Whiteside, T. L., Sustained outgrowth of autotumor-reactive T lymphocytes from human ovarian carcinomas in the presence of tumor necrosis factor-α and interleukin-2. Hum. Immunol. 1990. 28: 216-222.
43. + T cells by TNF-α. Lymphokine Cytokine Res. 1991. 10: 307-313.
44. Smyth, M. J., Kelly, J. M., Baxter, A. G., Korner, H. and Sedgwick, J. D., An essential role for tumor necrosis factor in natural cell-mediated tumor rejection in the peritoneum. J. Exp. Med. 1998. 188: 1611-1619.
45. Smyth, M. J., Johnstone, R. W., Cretney, E., Haynes, N. M., Sedgwick, J. D., Konrer, H., Poulton, L. D. and Baxter, A. D., Multiple deficiencies underlie NK cell inactivity in lymphotoxin-a gene-tergeted mice. J. Immunol. 1999. 163: 1350-1353.
46. Vandenbeele, P., Declercq, W., Beyaert, R. and Fiers, W., Two tumour necrosis factor receptors: structure and function. Trends Cell. Biol. 1995. 5: 392-397.
47. 2 in lymphotoxin-induced inflammation: critical role of TNF-receptor 7 signalling. J. Immunol. 1998. 160: 485-489.
48. Baxevanis, C. N., Reclos, G. J. and Papamichail, M., Decreased HLA-DR antigen expression on monocytes causes impaired suppressor cell activity in multiple sclerosis. J. Immunol. 1990. 144: 4166-4171.
49. Baxevanis, C. N., Ishii, N., Nagy, Z. A. and Klein, J., H-2 controlled suppression of T cell response to lactate dehydrogenase B. J. Exp. Med. 1982. 156: 822-833.
50. Wada, H., Noguchi, Y., Marino, M. W., Dunn, A. R. and Old, L. J., T cell functions in granulocyte/macrophage colony-stimulating factor deficient mice. Proc. Natl. Acad. Sci. USA 1997. 94: 12557-12562.
51. Baxevanis, C. N., Gritzapis, A. D., Dedoussis, G. V. Z., Papadopoulos, N. G. and Papamichail, M., Induction of tumor-specific T lymphocyte responses in vivo by prothymosin α. Cancer Immunol. Immunother. 1995. 40: 410-418.
52. Nair, S. K., Boczkowski, D., Snyder, D. and Gilboa, E., Antigen-presenting cells pulsed with unfractionated tumor-derived peptides are potent tumor vaccines. Eur. J. Immunol. 1997. 27: 589-597.